Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naomi Kamau
Institutions:
Kenya Medical Research Institute,
KEMRI-Wellcome Trust Research Programme,
Wellcome Trust
Observed institutions:
Kenya Medical Research Institute,
St. Paul's University,
KEMRI-Wellcome Trust Research Programme,
Wellcome Trust
ORCID:
0000-0002-0709-4930
Observed ORCID:
0000-0002-0709-4930
OpenAlex ID:
A5028446404
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
2023
·
Derick Kimathi
, Aitana Juan-Giner
, et al.
·
The Lancet Infectious Diseases
·
20
PDF
Low-Dose Yellow Fever Vaccine in Adults in Africa
2025
·
Derick Kimathi
, Aitana Juan-Giner
, et al.
·
New England Journal of Medicine
·
17
PDF
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial
2026
·
Derick Kimathi
, Aitana Juan-Giner
, et al.
·
The Lancet
·
9
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
2023
·
Mainga Hamaluba
, Samuel Sang
, et al.
·
Wellcome Open Research
·
8
Determining the effect of sub-contractor’s expertise on service delivery in public hospitals in Nakuru County
2022
·
Naomi Kamau
, Paul Gesimba
, et al.
·
Journal of Business and Entrepreneurship (JBE)
·
1
PDF
Show more works
View as search
Works count:
5
Citation count:
55
H-index:
4
I10-index:
2
Year
Topic
Type